These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1972294)

  • 1. Role of eicosanoids as mediators of inflammation in inflammatory bowel disease.
    Stenson WF
    Scand J Gastroenterol Suppl; 1990; 172():13-8. PubMed ID: 1972294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.
    Sharon P; Stenson WF
    Gastroenterology; 1984 Mar; 86(3):453-60. PubMed ID: 6319219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
    Schmidt C; Kosché E; Baumeister B; Vetter H
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-dependent eicosanoid metabolism by concanavalin A-stimulated human monocytes in vitro. Synergism with phorbol ester indicates separate regulation of leukotriene B4 synthesis and release.
    Hoffman T; Brando C; Lizzio EF; Lee YL; Hansen M; Tripathi AK; Taplits M; Puri J; Bonvini E; Abrahamsen TG
    J Immunol; 1991 Jan; 146(2):692-700. PubMed ID: 1846160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease.
    Sharon P; Stenson WF
    Gastroenterology; 1985 Jan; 88(1 Pt 1):55-63. PubMed ID: 3917261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
    Tornhamre S; Edenius C; Smedegård G; Sjöquist B; Lindgren JA
    Eur J Pharmacol; 1989 Oct; 169(2-3):225-34. PubMed ID: 2572437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
    Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotrienes and lipoxygenase factors: mediators and modulators of the allergic reaction.
    Konig W; Bohn A; Bremm KD; Müller P; Szperalski B; Pfeiffer P
    Allergol Immunopathol (Madr); 1982; 10(5):385-94. PubMed ID: 6187199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
    Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
    J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation.
    Hommes DW; Meenan J; de Haas M; ten Kate FJ; von dem Borne AE; Tytgat GN; van Deventer SJ
    Gut; 1996 Apr; 38(4):564-7. PubMed ID: 8707088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eicosanoids in hypoxic insult to neonatal rabbit bowel.
    Dollberg S; Udassin R; Ginat-Israeli T; Weidenfeld J; Branski D
    J Pediatr Gastroenterol Nutr; 1992 Aug; 15(2):130-4. PubMed ID: 1328580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease.
    Ikehata A; Hiwatashi N; Kinouchi Y; Yamazaki H; Ito K; Toyota T
    Scand J Gastroenterol; 1995 Jan; 30(1):44-9. PubMed ID: 7701249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosanoids and inflammatory bowel disease.
    Yang VW
    Gastroenterol Clin North Am; 1996 Jun; 25(2):317-32. PubMed ID: 9229575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of LTB4-like chemotactic arachidonate metabolites from human keratinocytes.
    Grabbe J; Rosenbach T; Czarnetzki BM
    J Invest Dermatol; 1985 Dec; 85(6):527-30. PubMed ID: 2999250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biology, pathophysiology and control of eicosanoids in inflammation.
    Higgins AJ
    J Vet Pharmacol Ther; 1985 Mar; 8(1):1-18. PubMed ID: 2985792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils.
    Nielsen OH; Ahnfelt-Rønne I; Elmgreen J
    Gut; 1987 Feb; 28(2):181-5. PubMed ID: 3030903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.
    Lobos EA; Sharon P; Stenson WF
    Dig Dis Sci; 1987 Dec; 32(12):1380-8. PubMed ID: 2826090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
    Rask-Madsen J; Bukhave K; Laursen LS; Lauritsen K
    Agents Actions; 1992; Spec No():C37-46. PubMed ID: 1359745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereospecificity of leukotriene B4 and structure-function relationships for chemotaxis of human neutrophils.
    Dahinden CA; Clancy RM; Hugli TE
    J Immunol; 1984 Sep; 133(3):1477-82. PubMed ID: 6086758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet thromboxane synthetase by sulfasalazine.
    Stenson WF; Lobos E
    Biochem Pharmacol; 1983 Jul; 32(14):2205-9. PubMed ID: 6135423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.